Omeros reported $-34768000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acelrx Pharmaceuticals ACRX:US $ -8.57M 0.86M
Adma Biologics ADMA:US $ -13.22M 1.62M
Aerie Pharmaceuticals AERI:US $ -32.04M 85.4M
Alnylam Pharmaceuticals ALNY:US $ -137.27M 45.91M
Biomarin Pharmaceutical BMRN:US $ 56.67M 96.56M
Cytokinetics CYTK:US $ -76.52M 58.35M
Dynavax Technologies DVAX:US $ 32.46M 49.7M
Gilead Sciences GILD:US $ 3422M 1947M
Heron Therapeutics HRTX:US $ -62.2M 9.46M
Insmed INSM:US $ -98173000 1.78M
Intercept Pharmaceuticals ICPT:US $ -9.9M 10.55M
Knight Therapeutics Inc GUD:CN C$ 13.06M 7.1M
Macrogenics MGNX:US $ -63725000 8.44M
Mirati Therapeutics MRTX:US $ -183.59M 12.92M
Pacira Pharmaceuticals PCRX:US $ 41.76M 17.12M
Pfizer PFE:US $ 11182M 4046M
Regulus Therapeutics RGLS:US $ -6.54M 0.28M
Sangamo Biosciences SGMO:US $ -42.43M 5.29M
Sarepta Therapeutics SRPT:US $ -76.16M 19.51M
United Therapeutics UTHR:US $ 300.5M 117.1M
Vertex Pharmaceuticals VRTX:US $ 1069.3M 159.74M
Vital Therapies VTL:US $ -21.41M 0.26M
Xoma XOMA:US $ -2063000 32.43M